Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors

Clinical trial NCT00106626 · COMPLETED

Trial details

NCT number: NCT00106626
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2005-08-01
Primary completion: 2007-12-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.